Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alternate Health Club vs Medro

Alternate Health Club
Graded #111

Higher grade

vs+6.199999999999996
Medro
Graded #252

Lower grade

The verdict

Alternate Health Club takes it — 69.8/100 to 63.6/100.

Alternate Health Club grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Alternate Health Club (alternatehealthclub.com) is a LegitScript-verified compounded GLP-1 telehealth platform offering compounded semaglutide at $129/month and compounded tirzepatide at $169/month.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAlternate Health Club +34
84
50
Dose & formulationMedro +13
64
77
Clinical oversightAlternate Health Club +6
77
71
Labs & monitoringEven
52
52
FulfillmentMedro +22
70
92
Contract termsAlternate Health Club +22
55
33
Alternate Health Club · left barMedro · right bar

The numbers

MetricAlternate Health ClubMedro
WeighScore69.8/10063.6/100
GradeCC
Scorecard rank#111#252
Semaglutide$129/mo (compounded)$199/mo (compounded)
Tirzepatide$169/mo (compounded)$299/mo (compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Alternate Health Club

Graded #111 · C

Strengths

  • $129/month compounded semaglutide is among the cheapest in the US market
  • $169/month compounded tirzepatide is competitive with established platforms
  • Complimentary workout and dietary plans bundled with medication — most peers don't
  • LegitScript verified
  • US-licensed clinicians

Where it loses points

  • Parent company / legal entity not publicly disclosed
  • State of incorporation not disclosed
  • Per-state availability not listed — confirm your state ships before committing
  • Pharmacy partners not publicly named
  • Unclear whether lab work is included
Medro

Graded #252 · C

Strengths

  • Covers both compounded semaglutide and tirzepatide and can prescribe brand-name GLP-1s when clinically appropriate.
  • LegitScript-certified (seal #50716646), available in all 50 states, with tiered pricing shown before checkout.
  • No membership fee and free expedited shipping on all orders; online intake with no appointment required in many cases.
  • Prices drop with longer commitments (semaglutide to $149/mo, tirzepatide to $224/mo on a 12-month plan).

Where it loses points

  • Does not name its compounding pharmacy or its clinical partner medical group, so the fulfillment chain is not verifiable.
  • Pricing is described as illustrative and may change by dose, pharmacy availability, and eligibility — final cost shows only at checkout.
  • Very new brand (2026, trademark pending) spanning many verticals, with a short track record in GLP-1 care.
  • Compounded medications are not FDA-approved or therapeutically equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound.

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard